Trial Profile
AVIDA The Vidaza (Azacitidine) Patient Registry.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jul 2019
Price :
$35
*
At a glance
- Drugs Azacitidine (Primary)
- Indications Myelodysplastic syndromes
- Focus Therapeutic Use
- Acronyms AVIDA
- Sponsors Celgene Corporation
- 09 Jan 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 Mar 2010 Planned end date changed from 1 Dec 2009 to 1 Jun 2010 as reported by ClinicalTrials.gov.